Abstract

In a issue of this journal, Crandall and colleagues [1] reported a positive association between percent mammo-graphic and bone mineral at the hip and lumbar spine in postmenopausal women. These associations were only observed after excluding women who were users of hormone replacement therapy and even then were of marginal, and not independent, significance (p = 0.04 and p = 0.08, respectively). The previously reported null findings from the larger studies by Kerlikowske and colleagues [2] and Buist and colleagues [3] were discounted by Crandall and colleagues [1] for not having stratified by hormone replacement therapy use. In a publication from our twin study we found no overlap between the genetic determinants of variation in percent mammographic and bone mineral [4]. We have now analysed our data on 268 pre- and postmenopausal female twins following the approach of Crandall and colleagues [1]. We fitted linear regression models with robust standard errors that took into account the clustering within twin pairs. Percent mammographic was the outcome variable and bone mineral measures (g/cm2) were the key exposure variables. As in Crandall and colleagues [1], we adjusted for age, body mass index (weight kg/height m2) and smoking (ever/never), even though there was no evidence in our data that smoking was associated with percent mammographic density. We found no evidence of a positive association with bone mineral at the hip or lumbar spine either overall or for women who were not current or users of hormone replacement therapy (Table ​(Table1)1) and no tests of interaction between hormone replacement therapy use and bone mineral were significant. After restricting analyses to postmenopausal women and stratification by use of hormone replacement therapy, to replicate the analyses of Crandall and colleagues [1], the lack of an association persisted both for women who were past or never users and for women who were current or users. Similar results were obtained for analyses of bone mineral at the forearm and femoral neck and total body bone mineral content (data not shown). There was also no evidence that recent hormone use has residual effects that may obscure the [putative positive] association between mammographic and bone mineral density [1]. Table 1 Regression coefficients for the effect of bone mineral measures on percent mammographic density, adjusting for age, body mass index and smoking Consequently, Crandall and colleagues' [1] claims of a positive association between mammographic and bone mineral and for a unifying biological mechanism behind bone mineral density, mammographic and breast cancer risk may be overstated. Their apparent finding may be an artefact of having conducted multiple analyses, having been misled by outliers or influential points, chance or by assuming effect modification without having tested for it. It may also reflect a true association but, given others' null findings [2,3], may be weaker than reported. As we have discussed [5], the absence of a strong association between mammographic and bone mineral may be an important observation; hormonal factors may explain little of the large variation across the population in mammographic density.

Highlights

  • Gillian S Dite1, John D Wark2, Graham G Giles3, Dallas R English3,4, Margaret RE McCredie5 and John L Hopper1

  • In a recent issue of this journal, Crandall and colleagues [1] reported a positive association between percent mammographic density and bone mineral density at the hip and lumbar spine in postmenopausal women

  • The previously reported null findings from the larger studies by Kerlikowske and colleagues [2] and Buist and colleagues [3] were discounted by Crandall and colleagues [1] for not having stratified by hormone replacement therapy use

Read more

Summary

Introduction

Gillian S Dite1, John D Wark2, Graham G Giles3, Dallas R English3,4, Margaret RE McCredie5 and John L Hopper1. In a recent issue of this journal, Crandall and colleagues [1] reported a positive association between percent mammographic density and bone mineral density at the hip and lumbar spine in postmenopausal women. The previously reported null findings from the larger studies by Kerlikowske and colleagues [2] and Buist and colleagues [3] were discounted by Crandall and colleagues [1] for not having stratified by hormone replacement therapy use.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call